Same Indication

Ipilimumab vs Warfarin

Ipilimumab vs Warfarin: Overview

This comparison examines the pharmacological differences between Ipilimumab and Warfarin.

Mechanism of Action

Ipilimumab: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

Warfarin: Inhibits vitamin K epoxide reductase complex.

Pharmacokinetics

Half-life: Ipilimumab — 14.7 days; Warfarin — 20-60 hours.

Chemical Properties

Molecular Formula: Warfarin — C19H16O4.

Molecular Weight: Warfarin — 308.3280 g/mol.

Type: Ipilimumab — Antibody; Warfarin — Small molecule.